Delivery Of Ibuprofen Research Articles

Nanoassemblies constructed from bimodal mesoporous silica nanoparticles and surface-coated multilayer pH-responsive polymer for controlled delivery of ibuprofen.

The pH-sensitive poly(D-A) grafted amine-functionalized bimodal mesoporous silica (D-A/BMMs) was prepared by a facile method used as a drug delivery vehicle. They exhibited superior properties such as good dispersion in aqueous medium, high drug loading efficiency, improved stability and high drug release rates. Meanwhile, its structural features and performances in a controlled delivery of ibuprofen (IBU) were systematically investigated by using XRD, N2 adsorption and desorption, SEM, TEM, FT-IR, elemental analysis and TG techniques. The results demonstrated that the obtained nanocomposite presented a flexible control over drug release by controlling the grafting amount of D-A onto the mesopores surface of aminated BMMs. The cumulative percent release of IBU from D-A/BMMs was found to be much higher at pH 7.4 than at pH 2.0. The release rate was very slow in an acidic medium but became faster in a neutral medium, owing to hydrogen bonding in an acidic medium and electrostatic repulsion between negatively charged carboxyl groups in an alkaline medium.

Formulation of hydrogel-thickened nonionic microemulsions with enhanced percutaneous delivery of ibuprofen assessed in vivo in rats

The study investigated usage of hydrogel of an anionic polymer xanthan gum for design of ibuprofen-loaded hydrogel-thickened microemulsions (HTMs) from the nonionic oil-in-water microemulsion (M). Xanthan gum demonstrated the performances of a thickening agent in physically stable HTMs at 5±3°C, 20±3°C, and 40±1°C during 6months. The results of physicochemical characterization (pH, conductivity, rheological behaviour, spreadability) indicated that HTMs containing 0.25–1.00% of the polymer had colloidal structure with oil nanodroplets of 14.34±0.98nm (PdI 0.220±0.075) dispersed in aqueous phase thickened with the polymer gel network which strength depended on the polymer concentration. HTMs with ibuprofen (5%) were evaluated as percutaneous drug delivery carriers. In vitro ibuprofen release from HTMs followed zero order kinetic (r>0.995) for 12h, while the referent hydrogel was described by Higuchi model. The HTM with optimized drug release rate and spreadability (HTM1) and the polymer-free microemulsion (M) were assessed and compared with the referent hydrogel in in vivo studies in rats. HTM1 and M were significantly more efficacious than reference hydrogel in producing antihyperalgesic and at lower extent antiedematous activity in prophylactic topical treatment protocol, whilst they were comparable in producing antihyperalgesic/antiedematous effects in therapeutic protocol. Topical treatments produced no obvious skin irritation.

Ibuprofen-conjugated hyaluronate/polygalacturonic acid hydrogel for the prevention of epidural fibrosis.

The formation of fibrous tissue is part of the natural healing response following a laminectomy. Severe scar tissue adhesion, known as epidural fibrosis, is a common cause of failed back surgery syndrome. In this study, by combining the advantages of drug treatment with a physical barrier, an ibuprofen-conjugated crosslinkable polygalacturonic acid and hyaluronic acid hydrogel was developed for epidural fibrosis prevention. Conjugation was confirmed and measured by 1D(1)H NMR spectroscopy.Invitroanalysis showed that the ibuprofen-conjugated polygalacturonic acid-hyaluronic acid hydrogel showed low cytotoxicity. In addition, the conjugated ibuprofen decreased prostaglandin E2production of the lipopolysaccharide-induced RAW264.7 cells. Histological data ininvivostudies indicated that the scar tissue adhesion of laminectomized male adult rats was reduced by the application of our ibuprofen-conjugated polygalacturonic acid-hyaluronic acid hydrogel. Its use also reduced the population of giant cells and collagen deposition of scar tissue without inducing extensive cell recruitment. The results of this study therefore suggest that the local delivery of ibuprofenviaa polygalacturonic acid-hyaluronic acid-based hydrogel reduces the possibility of epidural fibrosis.

Pegylated Polyaspartamide-Polylactide-Based Nanoparticles Penetrating Cystic Fibrosis Artificial Mucus.

Here, the preparation of mucus-penetrating nanoparticles for pulmonary administration of ibuprofen in patients with cystic fibrosis is described. A fluorescent derivative of α,β-poly(N-2-hydroxyethyl)-D,L-aspartamide is synthesized by derivatization with rhodamine, polylactide, and poly(ethylene glycol), to obtain polyaspartamide-polylactide derivatives with different degrees of pegylation. Starting from these copolymers, fluorescent nanoparticles with different poly(ethylene glycol) content, empty and loaded with ibuprofen, showed spherical shape, colloidal size, slightly negative ζ potential, and biocompatibility toward human bronchial epithelial cells. The high surface poly(ethylene glycol) density of fluorescent nanoparticles and poly(ethylene glycol) brush-like conformation assumed on their surface, conferred to pegylated nanoparticles the mucus-penetrating properties, properly demonstrated by assessing their ability to avoid interactions with mucus components and to penetrate cystic fibrosis artificial mucus. Finally, ibuprofen release profile and uptake capacity within human bronchial epithelial cells in the presence of cystic fibrosis artificial mucus showed how these mucus-penetrating nanoparticles could rapidly diffuse through the mucus barrier reaching the mucosal surface, where they could offer a sustained delivery of ibuprofen at the site of disease.

Delivery of ibuprofen by natural macroporous sporopollenin exine capsules extracted from Phoenix dactylifera L.

Sporopollenin macroporous capsules (SMCs) were extracted from date palm (Phoenix dactylifera L.) spores and coated by a natural polymer composite (chitosan with glutaraldehyde). The polymer coated macroporous capsules SMC@poly were used in the in vitro-controlled delivery of ibuprofen. The materials obtained were characterized through spectral, thermal, scanning electron microscopy (SEM), X-ray diffraction (XRD), and nitrogen adsorption–desorption isotherms. The IBU loading and releasing was studied by investigating the changes in various factors such as pH, temperature, and initial concentration. The results revealed that the loading of IBU increased when the concentration of IBU was decreased, following the Langmuir adsorption isotherm. The maximum loading of the IBU was observed at pH6.0 (97.2%, with 50mg/mL). The releasing results indicate that IBU was released faster when the pH was changed from 1.4 to 7.4. In addition, the cytotoxicity of the SMC, SMC@poly, and SMC@poly–IBU were tested against human intestinal Caco-2 cell line using MTT assay, and the results revea'led that all the materials in this study were biocompatible.

Collagen-based biomaterials for ibuprofen delivery

Drug delivery systems based on collagen sponges have increasingly become interesting materials for different medical applications. In this paper we present the obtaining, characterization and in vitro release of ibuprofen from collagen-based biomaterials in the form of sponges. The structural and morphological characteristics of these materials were investigated by infrared spectroscopy (FT-IR) and water uptake tests. Collagenase degradation, anti-inflammatory drug release and the kinetic mechanism are also discussed. The results obtained suggest that these new systems based on collagen have good potential for sustained release of analgesic and anti-inflammatory agents such as ibuprofen and the combination of collagen and ibuprofen as a sponge is a promising therapeutic method for the treatment of dental problems.

Interfacial synthesis of magnetic PMMA@Fe3O4/Cu3(BTC)2 hollow microspheres through one-pot Pickering emulsion and their application as drug delivery

Novel PMMA@Fe3O4/Cu3(BTC)2 hollow microspheres were fabricated through a convenient one-pot Pickering emulsion system, which showed synergetic multi-functions for ibuprofen delivery.

Evaluation of Ibuprofen Colon Delivery System using Grewia mollis Juss. (Tiliaceae) stem bark gum as Matrix-former

Aim: The aim of this research was to evaluate Grewia gum as a matrix-former for colon delivery of ibuprofen. Methodology: The gum was extracted by soaking the dried stem bark powder in aqueous solution of sodium metabisulphite for 48 h. Ibuprofen granules were prepared by wet granulation method using Grewia gum at 10, 20, 30, 40 and 50% w/w. The tablets were compressed using 12 mm punch. The physicochemical parameters-uniformity of weight, thickness, diameter, crushing strength, friability, disintegration time were evaluated. The in vitro drug release studies were conducted in simulated gastric fluid at 37 ± 1° and 100 rpm. The kinetics and mechanism of drug release were determined. The tablets were compared with those of hydroxypropylmethyl cellulose (HPMC) (80-120 cp; H9262) at the same concentrations. Results: The results revealed that Grewia gum is highly viscous, not readily soluble in water and has a high swelling capacity (237.5% w/w). It also has moderate flow profile, and large particle size. The matrix tablets containing 40 and 50 % w/w of Grewia gum exhibited highest swelling capacity and showed better ability to offer barrier to drug release in the upper GIT and delivery to colon. None of the matrix containing HPMC was able to prevent drug release in the upper GIT. The in vitro drug release in the absence and presence of rat cecal contents showed no significant difference (p<0.05) using ANOVA. The release kinetics followed zero-order and the mechanism of release was Korsmeyer-peppas super case II mechanism. Conclusion: The findings show that Grewia gum may be used as an effective matrix-former for the delivery of ibuprofen to colon.

Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen

Context: Nanostructured lipid carrier (NLC) dispersions present low viscosity and poor mucoadhesive properties, which reduce the pre-corneal residence time and consequently, the bioavailability of ocular drugs.Objective: The aim of this study was to prepare thermoresponsive eyedrops based on the combination of lipid nanoparticles and a thermoresponsive polymer with mucomimetic properties (Pluronic® F-127).Materials and methods: NLCi dispersions were prepared based on the melt-emulsification and ultrasonication technique. Physicochemical and morphological characteristics of the colloidal dispersions were evaluated. The formulation was also investigated for potential cytotoxicity in Y-79 human retinoblastoma cells and the in vitro drug release profile of the ibuprofen was determined.Results: NLCi showed a Z-average below 200 nm, a highly positive zeta potential and an efficiency of encapsulation (EE) of ∼90%. The gelification of the NLCi dispersion with 15% (w/w) Pluronic® F-127 did not cause significant changes to the physicochemical properties. The potential NLC-induced cytotoxicity was evaluated by the Alamar Blue reduction assay in Y-79 cells, and no relevant cytotoxicity was observed after exposure to 0–100 µg/mL NLC for up to 72 hours. The optimized formulations showed a sustained release of ibuprofen over several hours.Discussion and conclusion: The strategy proposed in this work can be successfully used to increase the bioavailability and the therapeutic efficacy of conventional eyedrops.

Rheological behavior and Ibuprofen delivery applications of pH responsive composite alginate hydrogels

Synthesis and structural characterization of hydrogels composed of sodium alginate, polyethylene oxide and acrylic acid with cyclodextrin as the hydrocolloid prepared at different pH values is presented. The hydrogels synthesized show significant variations in rheological properties, drug encapsulation capability and release kinetics. The hydrogels prepared at lower pH (pH 1) are more elastic, have high tensile strength and remain almost unaffected by varying temperature or frequency. Further, their Ibuprofen encapsulation capacity is low and releases it slowly. The hydrogel prepared at neutral pH (pH 7) is viscoelastic, thermo-reversible and also exhibits sol–gel transition on applying frequency and changing temperature. It shows highest Ibuprofen encapsulation capacity and also optimum drug release kinetics. The hydrogel prepared at higher pH (pH 12) is more viscous, has low tensile strength, is unstable to change in temperature and has fast drug release rate. The study highlights the pH responsiveness of three composite alginate hydrogels prepared under different conditions to be employed in drug delivery applications.

Controllable and switchable drug delivery of ibuprofen from temperature responsive composite nanofibers

Abstract Composited electrospun nanofibers made of temperature-responsive poly(N-isopropylacrylamide) (pNIPAM) and biodegradable poly (ε-caprolactone) (PCL) can be utilized for ‘on-demand’ and controlled drug release of ibuprofen without burst effect for potential pharmaceutical applications. Three types of nanofibers, PCL, pNIPAM and pNIPAM/PCL composite NFs containing ibuprofen were fabricated using electrospinning techniques. Ibuprofen release rates from PCL NFs are not affected by the temperature in the range of 22–34°C (less than 10%). In contrast, the ibuprofen release rates from pNIPAM NFs are very sensitive to the change in temperature, which is five times higher at 22°C compared to 34°C. However, there is a serious burst effect at 22°C. Compared to other two types of NFs, pNIPAM/PCL composite NFs prepared demonstrated a variable and controlled release at both room and higher temperature, due to the extra protection from the hydrophobic poly (ε-caprolactone). The rate at 22°C is 75% faster compared to that at 34°C. This kind of composite design can provide a novel approach to suppress the burst effect in drug delivery systems for potential pharmaceutical applications.

Design of Block Copolymer Costabilized Nonionic Microemulsions and Their In Vitro and In Vivo Assessment as Carriers for Sustained Regional Delivery of Ibuprofen via Topical Administration

Nonionic surfactants (caprylocaproyl macrogol-8 glycerides, octoxynol-12, polysorbate-20, and polyethylene glycol-40 hydrogenated castor oil) (47.03%, w/w), costabilizer (poloxamer 407) (12%-20%, w/w), oil (isopropyl myristate) (5.22%, w/w), water (q.s. ad 100%, w/w), and ibuprofen (5%, w/w) were used to develop oil-in-water microemulsions with Newtonian flow behavior, low viscosity (from 368 ± 38 to 916 ± 46 mPa s), and average droplet size from 14.79 ± 0.31 to 16.54 ± 0.75 nm. Ibuprofen in vitro release from the microemulsions was in accordance with zero-order kinetics (R0(2) > 0.99) for at least 12 h. The maximum drug release rate (3.55%h(-1) ) was from the microemulsion M3 comprising 16%, w/w of poloxamer 407. The release rate of ibuprofen from the reference hydrogel followed Higuchi kinetics (RH(2) > 0.99), and drug amount released after the 6th hour was negligible. In a rat model of inflammation, the microemulsion M3 was significantly more efficacious than the reference hydrogel in exerting antihyperalgesic effects in prophylactic topical treatment, whereas they were comparable in therapeutic treatment as well as in producing antiedematous effect in both protocols. No obvious skin irritation was observed in in vivo studies. The developed nonionic surfactants-based microemulsions containing the optimal concentration of poloxamer 407 could be promising carriers for sustained regional delivery of ibuprofen via topical administration.

Synthesis Mechanism and Thermal Optimization of an Economical Mesoporous Material Using Silica: Implications for the Effective Removal or Delivery of Ibuprofen.

Mesoporous silica materials (MSMs) were synthesized economically using silica (SiO2) as a precursor via a modified alkaline fusion method. The MSM prepared at 500°C (MSM–500) had the highest surface area, pore size, and volume, and the results of isotherms and the kinetics of ibuprofen (IBP) removal indicated that MSM–500 had the highest sorption capacity and fastest removal speed vs. SBA–15 and zeolite. Compared with commercial granular activated carbon (GAC), MSM–500 had a ~100 times higher sorption rate at neutral pH. IBP uptake by MSM–500 was thermodynamically favorable at room temperature, which was interpreted as indicating relatively weak bonding because the entropy (∆adsS, –0.07 J mol–1 K–1) was much smaller. Five times recycling tests revealed that MSM–500 had 83–87% recovery efficiencies and slower uptake speeds due to slight deformation of the outer pore structure. In the IBP delivery test, MSM–500 drug loading was 41%, higher than the reported value of SBA–15 (31%). The in vitro release of IBP was faster, almost 100%, reaching equilibrium within a few hours, indicating its effective loading and unloading characteristics. A cost analysis study revealed that the MSM was ~10–70 times cheaper than any other mesoporous silica material for the removal or delivery of IBP.

PH-responsive ordered mesoporous carbons for controlled ibuprofen release

Nitrogen-doped ordered mesoporous carbons (N-OMCs) were synthesized by nanocasting using SBA-15 silica as template and two polyaramide precursors: m-aminobenzoic acid (MABA) and p-aminobenzoic acid (PABA). The structure of the resulting materials was greatly influenced by the precursor used, since MABA yielded a CMK-3 type OMC, while PABA gave a CMK-5 one. Both carbons displayed differences in texture, structure and surface chemistry. These were reflected in a different pH dependence of ibuprofen adsorption and release. Although the two carbons exhibited a good behavior as drug adsorbents, the PABA-derived one was more efficient, in terms of drug delivery, than the carbon prepared from MABA, which was associated to the surface chemical nature and tube-like structure of the former. The desorption kinetics of both carbons presented an initial fast stage, reach the maximum ibuprofen delivery in 300min and the maximum drug concentration level remained constant up to 24h. Moreover, the carbons also exhibited a specific response toward the pH, which was associated to their different surface chemical and textural properties. This pH-responsive property was more evident for the PABA derived carbon, which allowed a sustained drug level of 10wt.% at pH=2 and of almost 40wt.% at pH=7.4.

Ex vivo skin permeation and retention studies on chitosan–ibuprofen–gellan ternary nanogel prepared by in situ ionic gelation technique—a tool for controlled transdermal delivery of ibuprofen

The chemical potentials of drug–polymer electrostatic interaction have been utilized to develop a novel ternary chitosan–ibuprofen–gellan nanogel as controlled transdermal delivery tool for ibuprofen. The ternary nanogels were prepared by a combination of electrostatic nanoassembly and ionic gelation techniques. The electrostatic and hydrophobic interactions as well as hydrogen bonding between ibuprofen and chitosan were confirmed with FTIR, while DSC, TGA and SEM confirmed the physical state, thermal and morphological characteristics, respectively. The ex vivo delivery of ibuprofen onto and across the skin was evaluated based on system specific drug release parameters such as steady state permeation rate, permeability coefficient, permeability enhancement ratio, skin/gel partition coefficient, diffusion coefficient, lag time and release rate constant and mechanisms of release were determined using mathematical models. Interaction between ibuprofen and chitosan produced new spherical eutectic nanoconjugates with remarkable decrease in particle size of ibuprofen from 4580 (length-to-breadth aspect ratio) to a minimum of 14.15nm (324-times), and thermally stable amorphous characteristics. The nanogels exhibited significant elastic and pseudoplastic characteristics dictated by the concentration of chitosan with maximum swelling capacity of 775% w/w at 6.55mM chitosan compared with 281.16 and 506.50% for plain gellan and control ibuprofen hydrogel, respectively. Chitosan enhanced the skin penetration, permeability and the rate of transdermal release of ibuprofen by a factor of 4, dictated by the extent of ibuprofen–chitosan ionic interaction and its concentration. The major mechanism of ibuprofen release through the pig skin was drug diffusion however drug partition and matrix erosion also occurred. It was evident that ternary nanogels are novel formulations with potential application in controlled transdermal delivery of ibuprofen.

Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen

Suitability of liquid lecithin (i.e., solution of lecithin in soy bean oil with ∼60% w/w of phospholipids) for formation of gels, upon addition of water solution of poloxamer 407, was investigated, and formulated systems were evaluated as carriers for percutaneous delivery of ibuprofen. Formulation study of pseudo-ternary system liquid lecithin/poloxamer 407/water at constant liquid lecithin/poloxamer 407 mass ratio (2.0) revealed that minimum concentrations of liquid lecithin and poloxamer 407 required for formation of gel like systems were 15.75% w/w and 13.13% w/w, respectively, while the maximum content of water was 60.62% w/w. The systems comprising water concentrations in a range from 55 to 60.62% w/w were soft semisolids suitable for topical application, and they were selected for physicochemical and biopharmaceutical evaluation. Analysis of conductivity results and light microscopy examination revealed that investigated systems were water dilutable dispersions of spherical oligolamellar associates of phospholipids and triglyceride molecules in the copolymer water solution. Rheological behavior evaluation results indicated that the investigated gels were thermosensitive shear thinning systems. Ibuprofen (5% w/w) was incorporated by dispersing into the previously prepared carriers. Drug-loaded systems were physically stable at storage temperature from 5±3°C to 40±2°C, for 30 days. In vitro ibuprofen release was in accordance with the Higuchi model (rH>0.95) and sustained for 12h. The obtained results implicated that formulated LLPBGs, optimized regarding drug release and organoleptic properties, represent promising carriers for sustained percutaneous drug delivery of poorly soluble drugs.

Development and optimization of sustained release polymeric microparticles by screening design

The aim of the present study was to investigate the effect of processing and formulation variables on polymeric microparticles, intended to be used for sustaining drug delivery of ibuprofen. Ibuprofen, polycaprolactone, dichloromethane (DCM), water, stirring speed and polyvinyl alcohol were selected as independent variables during the microparticles preparation. The independent variables influencing encapsulation efficiency (E.E.) and physical characteristics were assessed. The resultant microparticles were characterized for their E.E., surface morphology, and in vitro drug release. Ibuprofen loaded polymeric microparticles were characterized by FESEM, FTIR, DSC, and XRPD analysis. Graphical and mathematical analysis of the design showed that ibuprofen, polycaprolactone and DCM were significant effect on the E.E. of the microparticles. The low magnitudes of error and the significant values of R2 in the present investigation prove the high prognostic ability of the design. The microparticles showed high E.E. (76.11 ± 0.06–104.9 ± 0.46 %) with average particle size of 5–100 μm. The microparticles were found to be discrete, spherical with smooth surface. The FTIR analysis confirmed the compatibility of ibuprofen with the polymers. The XRPD and DSC study revealed the dispersion of drug within microparticles formulation. In vitro study showed sustain drug release over 12 h, thus prolong the drug action to treat the musculoskeletal disorder.

Temperature and pH Responsive Microfibers for Controllable and Variable Ibuprofen Delivery

Electrospun microfibers (MFs) composed of pH and temperature responsive polymers can be used for controllable and variable delivery of ibuprofen. First, electrospinning technique was employed to prepare poly(ε-caprolactone) (PCL) and poly(N-isopropylacrylamide-co-methacrylic acid) (pNIPAM-co-MAA) MFs containing ibuprofen. It was found that drug release rates from PCL MFs cannot be significantly varied by either temperature (22–40°C) or pH values (1.7–7.4). In contrast, the ibuprofen (IP) diffusion rates from pNIPAM-co-MAA MFs were very sensitive to changes in both temperature and pH. The IP release from pNIPAM-co-MAA MFs was highly linear and controllable when the temperature was above the lower critical solution temperature (LCST) of pNIPAM-co-MAA (33°C) and the pH was lower than thepKaof carboxylic acids (pH 2). At room temperature, however, the release rate was dramatically increased by nearly ten times compared to that at higher temperature and lower pH. Such a unique and controllable drug delivery system could be naturally envisioned to find many practical applications in biomedical and pharmaceutical sciences such as programmable transdermal drug delivery.

Enhancement of transdermal delivery of ibuprofen using microemulsion vehicle.

The objective of this study was to find a stable microemulsion vehicle for transdermal delivery of ibuprofen to improve the skin permeability. Microemulsion was prepared using different sorts of oils, surfactants and co-surfactants. Pseudo-ternary phase diagrams were used to evaluate the microemulsion domain. The effects of oleic acid and surfactant mixture on skin permeation of ibuprofen were evaluated with excised skins. The optimum formulation F3 consisting of 6% oleic acid, 30% Cremophor RH40/Transcutol P (2:1, w/w) and 59% water phase, showed a high permeation rate of 42.98 µg/cm(2)/hr. The mean droplet size of microemulsion was about 43 nm and no skin irritation signs were observed on the skin of rabbits. These results indicated that this novel microemulsion is a useful formulation for the transdermal delivery of ibuprofen.

Molecular Dynamics Simulations of Ibuprofen Release from pH-Gated Silica Nanochannels.

The iboprufen delivery process from cylindrical silica pores of 3 nm diameter, with polyamine chains anchored at the pore outlets, was investigated by means of massive molecular dynamics simulations. Effects from pH were introduced by considering polyamine chains with different degrees of protonation. High, low, and intermediate pH environments were investigated. The increment of the acidity of the environment leads to a significant decrease of the pore aperture, yielding an effective diameter, for the lowest pH case, that is 3.5 times smaller than the one associated with the highest pH one. Using a biased sampling procedure, Gibbs free energy profiles for the ibuprofen delivery process were obtained. The joint analysis of the corresponding profiles, time evolution of the ibuprofen position within the channel, orientation of the molecule, and instantaneous effective diameter of the gate suggest a three-step mechanism for ibuprofen delivery. A complementary analysis of the translational mobility of ibuprofen along the axial direction of the channel revealed a subdiffusive dynamics in the low and intermediate pH cases. Deviations from Brownian diffusive dynamics are discussed and compared with direct experimental results.